Cargando…

Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer

The majority of breast cancers (90–95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous s...

Descripción completa

Detalles Bibliográficos
Autores principales: Bednarczyk, Robert B., Tuli, Neha Y., Hanly, Elyse K., Rahoma, Ghada Ben, Maniyar, Rachana, Mittelman, Abraham, Geliebter, Jan, Tiwari, Raj K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966261/
https://www.ncbi.nlm.nih.gov/pubmed/29849939
http://dx.doi.org/10.18632/oncotarget.24917
_version_ 1783325431658708992
author Bednarczyk, Robert B.
Tuli, Neha Y.
Hanly, Elyse K.
Rahoma, Ghada Ben
Maniyar, Rachana
Mittelman, Abraham
Geliebter, Jan
Tiwari, Raj K.
author_facet Bednarczyk, Robert B.
Tuli, Neha Y.
Hanly, Elyse K.
Rahoma, Ghada Ben
Maniyar, Rachana
Mittelman, Abraham
Geliebter, Jan
Tiwari, Raj K.
author_sort Bednarczyk, Robert B.
collection PubMed
description The majority of breast cancers (90–95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous studies have demonstrated that up to 50% of the breast tumor comprise of tumor-associated macrophages (TAMs) and increased TAM infiltration has been associated with poor patient prognosis. Furthermore, breast cancer associated deaths are predominantly attributed to invasive cancers and metastasis with epithelial-mesenchymal transition (EMT) being implicated. In this study, we investigated the effects of cellular crosstalk between TAMs and breast cancer using an in vitro model system. M1 polarized THP-1 macrophage conditioned media (CM) was generated and used to evaluate cellular and functional changes of breast cancer lines T47D and MCF-7. We observed that T47D and MCF-7 exhibited a partial EMT phenotype in the presence of activated THP-1 CM. Additionally, MCF-7 displayed a significant increase in migratory and invasive properties. We conclude that M1 secretory factors can promote a partial EMT of epithelial-like breast cancer cells. The targeting of M1 macrophages or their secretory components may inhibit EMT and limit the invasive potential of breast cancer.
format Online
Article
Text
id pubmed-5966261
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-59662612018-05-30 Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer Bednarczyk, Robert B. Tuli, Neha Y. Hanly, Elyse K. Rahoma, Ghada Ben Maniyar, Rachana Mittelman, Abraham Geliebter, Jan Tiwari, Raj K. Oncotarget Research Paper The majority of breast cancers (90–95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous studies have demonstrated that up to 50% of the breast tumor comprise of tumor-associated macrophages (TAMs) and increased TAM infiltration has been associated with poor patient prognosis. Furthermore, breast cancer associated deaths are predominantly attributed to invasive cancers and metastasis with epithelial-mesenchymal transition (EMT) being implicated. In this study, we investigated the effects of cellular crosstalk between TAMs and breast cancer using an in vitro model system. M1 polarized THP-1 macrophage conditioned media (CM) was generated and used to evaluate cellular and functional changes of breast cancer lines T47D and MCF-7. We observed that T47D and MCF-7 exhibited a partial EMT phenotype in the presence of activated THP-1 CM. Additionally, MCF-7 displayed a significant increase in migratory and invasive properties. We conclude that M1 secretory factors can promote a partial EMT of epithelial-like breast cancer cells. The targeting of M1 macrophages or their secretory components may inhibit EMT and limit the invasive potential of breast cancer. Impact Journals LLC 2018-03-23 /pmc/articles/PMC5966261/ /pubmed/29849939 http://dx.doi.org/10.18632/oncotarget.24917 Text en Copyright: © 2018 Bednarczyk et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Research Paper
Bednarczyk, Robert B.
Tuli, Neha Y.
Hanly, Elyse K.
Rahoma, Ghada Ben
Maniyar, Rachana
Mittelman, Abraham
Geliebter, Jan
Tiwari, Raj K.
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
title Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
title_full Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
title_fullStr Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
title_full_unstemmed Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
title_short Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
title_sort macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966261/
https://www.ncbi.nlm.nih.gov/pubmed/29849939
http://dx.doi.org/10.18632/oncotarget.24917
work_keys_str_mv AT bednarczykrobertb macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT tulinehay macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT hanlyelysek macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT rahomaghadaben macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT maniyarrachana macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT mittelmanabraham macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT geliebterjan macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer
AT tiwarirajk macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer